IDEXX Labs (NASDAQ: IDXX) reported Q2 EPS of $0.60, $0.03 better than the analyst estimate of $0.57. Revenue for the quarter came in at $413 million versus the consensus estimate of $412.57 million.

IDEXX Labs reaffirmed FY2015 guidance.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.